Key Takeaways At AAIC 2025, the Alzheimer's Association released the first in a series of clinical practice guidelines for the diagnosis, treatment and care of Alzheimer's and all other ...

Although it's not always easy to determine if an individual can make decisions, a judge understands the obvious that a ...

Microglia, a type of brain immune cell, can gobble up amyloid beta protein, which clumps together into toxic aggregates ...

Scientists at UCSF have uncovered how certain immune cells in the brain, called microglia, can effectively digest toxic ...

The Alzheimer's Association® will present 10 scientific awards at the Alzheimer's Association International Conference® 2025 (AAIC®), recognizing researchers for their expertise, noteworthy ...

While there's no cure yet for Alzheimer's, researchers are finally making more progress in better understanding the disease and working on new treatments that may even reverse it.

Alzheimer’s disease could soon be a distant memory. A revolutionary new Alzheimer’s drug named lecanemab could mark a major breakthrough in the decades-long battle against the neurological ...

Trontinemab's Phase Ib/IIa Brainshuttle AD study continues to show rapid and robust clearance of amyloid plaques, with 91% becoming amyloid PET negative and ARIA-E remaining Design of the Phase III TR ...

Case Western Reserve researchers find that for every 1,000 seniors who had covid, seven will be diagnosed with Alzheimer’s disease within a year, slightly above the five-in-a-thousand diagnosis ...

However, unlike most clinical studies, no treatment is tested in ADNI. Instead, participants are followed over a period of years or decades with repeated imaging, including MRI and PET amyloid and tau ...

The Alzheimer’s Association Walk to End Alzheimer’s will take place at Burlington Athletic Stadium, 1450 Graham St., in ...